Učitavanje...
Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Should Baseline Characteristics Affect Choice of Treatment?
PURPOSE: Among eyes with proliferative diabetic retinopathy (PDR), identify whether baseline characteristics impact the benefit of ranibizumab over panretinal photocoagulation (PRP) in DRCR.net Protocol S. METHODS: Participants had PDR, visual acuity (VA) of 20/320 or better, and no prior PRP. Eyes...
Spremljeno u:
| Izdano u: | Retina |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6698425/ https://ncbi.nlm.nih.gov/pubmed/30807516 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/IAE.0000000000002377 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|